Trial Profile
Efficacy of Abatacept, Adalimumab and Rituximab in Patients with Rheumatoid Arthritis: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Adalimumab (Primary) ; Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 26 Aug 2016 New trial record